Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study

Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands.
Annals of Surgical Oncology (Impact Factor: 3.94). 02/2011; 18(8):2224-31. DOI: 10.1245/s10434-011-1607-5
Source: PubMed

ABSTRACT In 10-24% of patients with rectal cancer who are treated with neoadjuvant chemoradiation, no residual tumor is found after surgery (ypT0). When accurately selected, these complete responders might be considered for less invasive treatments instead of standard surgery. So far, no imaging method has proven reliable. This study was designed to assess the accuracy of diffusion-weighted MRI (DWI) in addition to standard rectal MRI for selection of complete responders after chemoradiation.
A total of 120 patients with locally advanced rectal cancer from three university hospitals underwent chemoradiation followed by a restaging MRI (1.5T), consisting of standard T2W-MRI and DWI (b0-1000). Three independent readers first scored the standard MRI only for the likelihood of a complete response using a 5-point confidence score, after which the DWI images were added and the scoring was repeated. Histology (ypT0 vs. ypT1-4) was the standard reference. Diagnostic performance for selection of complete responders and interobserver agreement were compared for the two readings.
Twenty-five of 120 patients had a complete response (ypT0). Areas under the ROC-curve for the three readers improved from 0.76, 0.68, and 0.58, using only standard MRI, to 0.8, 0.8, and 0.78 after addition of DWI (P = 0.39, 0.02, and 0.002). Sensitivity for selection of complete responders ranged from 0-40% on standard MRI versus 52-64% after addition of DWI. Specificity was equally high (89-98%) for both reading sessions. Interobserver agreement improved from κ 0.2-0.32 on standard MRI to 0.51-0.55 after addition of DWI.
Addition of DWI to standard rectal MRI improves the selection of complete responders after chemoradiation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective This meta-analysis aimed to compare the diagnostic accuracy of diffusion-weighted magnetic resonance imaging (DW-MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET) with or without computed tomography (CT) in evaluating and predicting pathological response to NCRT in patients with rectal cancer.Methods Comprehensive literature search was conducted in the manuscript published from January 2000 to December 2013 on the MEDLINE, PUBMED and EMBASE databases as well as on the SpringerLink, ScienceDirect, Scopus and the Cochrane Database of Systematic Review. Only articles in English were enrolled. Statistical value of combined sensitivity, specificity, positive (PPV) and negative predictive value (NPV) were calculated.ResultsAltogether 33 studies including 1564 patients, the pooled sensitivity (81% [95% confidence interval {CI} 74–86%] vs 85% [95% CI 75–91%]) and NPV (80% [95% CI 68–89%] vs 91% [95% CI 80–95%]) for FDG-PET or FDG-PET/CT were significantly lower than those for DW-MRI (P < 0.05). No differences were observed in the pooled specificity and PPV between DW-MRI and FDG-PET or FDG-PET/CT. Further subgroup analysis showed that DW-MRI yielded higher sensitivity on adenocarcinoma only than those including mucinous-type adenocarcinoma (92% [95% CI 83–99%] vs 76% [95% CI 63–90%], P = 0.00).ConclusionsDW-MRI might be a promising tool in predicting and evaluating the pathological response to preoperative NCRT in patients with rectal cancer and is superior to FDG-PET or FDG-PET/CT. However, the relatively low specificity and PPV will limit its application in clinic, making it not be currently appropriate for monitoring patients with mucinous-type rectal adenocarcinoma.
    Journal of Digestive Diseases 07/2014; · 1.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine diagnostic performance of simple measurements on diffusion-weighted MR imaging (DWI) for assessment of complete tumour response (CR) after neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer (LARC) by signal intensity (SI) and apparent diffusion coefficient (ADC) measurements.
    European Radiology 07/2014; 24(11). · 4.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rectal cancer accounts for a relevant part of colorectal cancer cases, with a mortality of 4-10/100000 per year. The development of locoregional recurrences and the occurrence of distant metastases both influences the prognosis of these patients. In the last two decades, new multimodality strategies have improved the prognosis of locally advanced rectal cancer with a significant reduction of local relapse and an increase in terms of overall survival. Radical surgery still remains the principal curative treatment and the introduction of total mesorectal excision has significantly achieved a reduction in terms of local recurrence rates. The employment of neoadjuvant treatment, delivered before surgery, also achieved an improved local control and an increased sphincter preservation rate in low-lying tumors, with an acceptable acute and late toxicity. This review describes the multidisciplinary management of rectal cancer, focusing on the effectiveness of neoadjuvant chemoradiotherapy and of post-operative adjuvant chemotherapy both in the standard combined modality treatment programs and in the ongoing research to improve these regimens.
    World journal of gastroenterology : WJG. 12/2014; 20(46):17279-17287.

Full-text (2 Sources)

Available from
Jun 2, 2014